se ha leído el artículo
array:24 [ "pii" => "S1578219012003216" "issn" => "15782190" "doi" => "10.1016/j.adengl.2012.03.022" "estado" => "S300" "fechaPublicacion" => "2012-12-01" "aid" => "693" "copyright" => "Elsevier España, S.L. and AEDV" "copyrightAnyo" => "2012" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2012;103:942-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1945 "formatos" => array:3 [ "EPUB" => 46 "HTML" => 1325 "PDF" => 574 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731012003493" "issn" => "00017310" "doi" => "10.1016/j.ad.2012.03.016" "estado" => "S300" "fechaPublicacion" => "2012-12-01" "aid" => "693" "copyright" => "Elsevier España, S.L. y AEDV" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2012;103:942-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2374 "formatos" => array:3 [ "EPUB" => 4 "HTML" => 1802 "PDF" => 568 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Sobre las ecuaciones para estimar el riesgo vascular en pacientes con psoriasis (REGICOR y SCORE)" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "942" "paginaFinal" => "943" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "On Cardiovascular Risk Estimation in Patients With Psoriasis: The REGICOR and SCORE Scales" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Labandeira García, J. Alonso-González" "autores" => array:2 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Labandeira García" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Alonso-González" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219012003216" "doi" => "10.1016/j.adengl.2012.03.022" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219012003216?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012003493?idApp=UINPBA000044" "url" => "/00017310/0000010300000010/v1_201304241557/S0001731012003493/v1_201304241557/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219012003228" "issn" => "15782190" "doi" => "10.1016/j.adengl.2012.07.021" "estado" => "S300" "fechaPublicacion" => "2012-12-01" "aid" => "694" "copyright" => "Elsevier España, S.L. and AEDV" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2012;103:943-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2004 "formatos" => array:3 [ "EPUB" => 48 "HTML" => 1461 "PDF" => 495 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Response to: “On Cardiovascular Risk Estimation in Patients With Psoriasis: The REGICOR and SCORE Scales”" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "943" "paginaFinal" => "944" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Respuesta a: Sobre las ecuaciones para estimar el riesgo vascular en pacientes con psoriasis (REGICOR y SCORE)" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "L. Puig" "autores" => array:1 [ 0 => array:2 [ "nombre" => "L." "apellidos" => "Puig" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S000173101200350X" "doi" => "10.1016/j.ad.2012.07.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173101200350X?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219012003228?idApp=UINPBA000044" "url" => "/15782190/0000010300000010/v1_201304241352/S1578219012003228/v1_201304241352/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1578219012003502" "issn" => "15782190" "doi" => "10.1016/j.adengl.2011.12.009" "estado" => "S300" "fechaPublicacion" => "2012-12-01" "aid" => "605" "copyright" => "Elsevier España, S.L. and AEDV" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2012;103:939-41" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2065 "formatos" => array:3 [ "EPUB" => 50 "HTML" => 1510 "PDF" => 505 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>" "titulo" => "Primary Cutaneous Aspergillosis Complicating Tumor Necrosis Factor-α Blockade Therapy in a Patient With Psoriasis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "939" "paginaFinal" => "941" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Aspergilosis cutánea primaria que complica el tratamiento con inhibidores del factor de necrosis tumoral α en un paciente con psoriasis" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1637 "Ancho" => 1583 "Tamanyo" => 189709 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Two colonies of <span class="elsevierStyleItalic">Aspergillus fumigatus</span> growing on solid Sabouraud medium with gentamicin and chloramphenicol (25<span class="elsevierStyleHsp" style=""></span>°C).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F. Osório, S. Magina, F. Azevedo" "autores" => array:3 [ 0 => array:2 [ "nombre" => "F." "apellidos" => "Osório" ] 1 => array:2 [ "nombre" => "S." "apellidos" => "Magina" ] 2 => array:2 [ "nombre" => "F." "apellidos" => "Azevedo" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0001731012001627" "doi" => "10.1016/j.ad.2011.12.014" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012001627?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219012003502?idApp=UINPBA000044" "url" => "/15782190/0000010300000010/v1_201304241352/S1578219012003502/v1_201304241352/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to editor</span>" "titulo" => "On Cardiovascular Risk Estimation in Patients With Psoriasis: The REGICOR and SCORE Scales" "tieneTextoCompleto" => true "saludo" => "<span class="elsevierStyleItalic">To the Editor:</span>" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "942" "paginaFinal" => "943" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "J. Labandeira García, J. Alonso-González" "autores" => array:2 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Labandeira García" ] 1 => array:4 [ "nombre" => "J." "apellidos" => "Alonso-González" "email" => array:1 [ 0 => "julio.alonso.gonzalez@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Departamento de Dermatología, Complejo Hospitalario Universitario, Facultad de Medicina, Santiago de Compostela, La Coruña, Spain" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Sobre las ecuaciones para estimar el riesgo vascular en pacientes con psoriasis (REGICOR y SCORE)" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We would like to congratulate the developers of the recently presented cardiovascular risk calculator<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> and to applaud the decision of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (AEDV) to facilitate the clinical practice of dermatologists by including it on their web page. However, we would also like to discuss 2 issues in the interest of making this new service more useful. If our suggestions are not considered feasible or appropriate at this time, they will at least serve to bring to light the range of views held among members of the AEDV.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Our first point concerns the main instruments available for assessing cardiovascular risk in Spain: we refer to the Systematic Coronary Risk Evaluation (SCORE) charts and the Girona Heart Registry (REGICOR) scales. The SCORE charts were calibrated for use in the Spanish population and seem to be recommended unanimously by the various scientific associations that have formed the Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention (CEIPC)<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a>; also calibrated and validated, the REGICOR scale is widely used in some of Spain's autonomous communities.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,4</span></a> Comparing risk functions between scales like these is complicated. Aspects usually considered include the rate of drug prescription based on one scoring system or another, agreement between scores, and an instrument's sensitivity and specificity when used. The manner of making such comparisons, however, lies outside the scope of this letter. We would simply like to note that our literature has seen a bitter debate about which of these 2 instruments is more appropriate for assessing cardiovascular risk in Spain<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5-9</span></a> and that discussants have sometimes overstepped the boundaries of science to include issues that cannot exactly be described as medical concerns. Consequently, we wonder if the AEDV working group's web posting of a calculator based on only one of these scales (the REGICOR) might mistakenly be interpreted as an explicit recommendation that it should be preferred for patients with psoriasis. If that were the case, the scientific rationale ought to be set out; in our opinion this would be complicated, controversial, certainly debatable, and something that lies outside the boundaries of our specialty. We therefore think it would be useful to add a link to the website where SCORE calculators are posted (<a href="http://www.heartscore.org/es/Pages/welcome.aspx">http://www.heartscore.org/es/Pages/welcome.aspx</a>), so that dermatologists can choose for themselves which tool to use for estimating cardiovascular risk in patients with psoriasis. This instrument, from the European Society of Cardiology, does not work on as many different platforms as the application already posted by the AEDV working group, but it is also free and can be used online or downloaded to a personal computer. Above all, we note that it comes with no advertisements.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Our second comment, in fact, refers to this last one, about the issue of advertising. The first time one accesses the REGICOR calculator from the AEDV working group's webpage, one is struck by seeing a tab labeled with the commercial name of a medication for treating psoriasis, along with the name of the laboratory that produces it. Later, once on the page, the laboratory's name is once more on display. Clicking on an icon underneath the name gives access to the REGICOR tool and other applications. After going through this process to assess several patients, one inevitably begins to wonder about the esthetics—not to mention the ethics—of this presentation, in which we see the name of a drug for treating psoriasis each time we need to estimate a psoriasis patient's cardiovascular risk. Although we are very grateful for the pharmaceutical industry's support, especially during these times of economic crisis, this presentation perhaps ought to be changed. If this is not possible, or is considered inadvisable at this time, we would simply like to remind readers that they can access the REGICOR calculator (to use online or to download) at the developers’ own website: <a href="http://www.regicor.org/">http://www.regicor.org</a>. Accessing the tool at that website has the advantage of being publicity-free, although it has the same drawback we have mentioned for the SCORE calculator: it is not so well adapted for use on many platforms as the one provided by the AEDV's working group.</p><p id="par0020" class="elsevierStylePara elsevierViewall">We believe that the dermatologist's interest should be centered only on detecting moderate to severe cardiovascular risk in patients being treated for psoriasis. Either scale can be used while we await more information on which one might work best. And as both are already available without advertisements, so much the better.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara">Please cite this article as: Labandeira García J, Alonso-González J. Sobre las ecuaciones para estimar el riesgo vascular en pacientes con psoriasis (REGICOR y SCORE). Actas Dermosifiliogr. 2012;103:942–3.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:9 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Calculadora multiplataforma para síndrome metabólico y riesgo cardiovascular en pacientes con psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R. Taberner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2011.11.003" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2012" "volumen" => "103" "paginaInicial" => "111" "paginaFinal" => "119" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22284865" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adaptación española del CEIPC 2008" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "del Comité Español Interdisciplinario para la Prevención Cardiovascular Guía Europea de Prevención Cardiovascular en la Práctica Clínica" "etal" => true "autores" => array:6 [ 0 => "J.M. Lobos" 1 => "M.A. Royo-Bordonada" 2 => "C. Brotons" 3 => "L. Álvarez-Sala" 4 => "P. Armario" 5 => "A. Maiques" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Esp Salud Pública" "fecha" => "2008" "volumen" => "82" "paginaInicial" => "581" "paginaFinal" => "616" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19180272" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Marrugat" 1 => "P. Solanas" 2 => "R. D’Agostino" 3 => "L. Sullivan" 4 => "J. Ordovás" 5 => "F. Cordón" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Esp Cardiol" "fecha" => "2003" "volumen" => "56" "paginaInicial" => "253" "paginaFinal" => "261" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12622955" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tablas de evaluación del riesgo coronario adaptadas a la población española. Estudio DORICA" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "grupo DORICA" "etal" => true "autores" => array:6 [ 0 => "J. Aranceta" 1 => "C. Pérez" 2 => "M. Foz" 3 => "T. Mantilla" 4 => "L. Serra" 5 => "B. Moreno" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2004" "volumen" => "123" "paginaInicial" => "686" "paginaFinal" => "691" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "La prevención según el Comité Español Interdisciplinario para la Prevención Cardiovascular: una valoración crítica" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "F. Miguel" 1 => "A. Merino" 2 => "M.J. Montero" 3 => "A. García-Ortiz" 4 => "R. Sanz" 5 => "J.A. Maderuelo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Esp Salud Pública" "fecha" => "2010" "volumen" => "84" "paginaInicial" => "185" "paginaFinal" => "201" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20571719" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Réplica del Comité Español Interdisciplinar para la Prevención Cardiovascular" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "en nombre del Comité Español Interdisciplinar para la Prevención Cardiovascular (CEIPC)" "etal" => false "autores" => array:6 [ 0 => "J.M. Lobos" 1 => "M.A. Royo-Bordonada" 2 => "C. Brotons" 3 => "A. Maiques" 4 => "F. Villar" 5 => "P. Conthe" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Esp Salud Pública" "fecha" => "2010" "volumen" => "84" "paginaInicial" => "331" "paginaFinal" => "336" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20661531" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparación entre la tabla del SCORE y la función de Framingham-REGICOR en la estimación del riesgo cardiovascular" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R. Ramos" 1 => "P. Solanas" 2 => "I. Subirana" 3 => "J. Vila" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2007" "volumen" => "128" "paginaInicial" => "477" "paginaFinal" => "478" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Análisis de la capacidad predictiva de las funciones de Framingham-REGICOR y SCORE en la población de un centro de salud" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "F. Buitrago" 1 => "L. Cañón Barroso" 2 => "N. Díaz Herrera" 3 => "E. Cruces" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2007" "volumen" => "129" "paginaInicial" => "797" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Criterios de validez y validación de las funciones de riesgo SCORE y REGICOR en la población de un centro de salud urbano" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "F. Buitrago" 1 => "L. Cañón Barroso" 2 => "A. García-Nogales" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Esp Salud Pública" "fecha" => "2010" "volumen" => "84" "paginaInicial" => "335" "paginaFinal" => "338" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20661532" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010300000010/v1_201304241352/S1578219012003216/v1_201304241352/en/main.assets" "Apartado" => array:4 [ "identificador" => "6208" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010300000010/v1_201304241352/S1578219012003216/v1_201304241352/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219012003216?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 12 | 14 | 26 |
2024 Octubre | 69 | 53 | 122 |
2024 Septiembre | 67 | 27 | 94 |
2024 Agosto | 95 | 56 | 151 |
2024 Julio | 62 | 38 | 100 |
2024 Junio | 74 | 41 | 115 |
2024 Mayo | 52 | 25 | 77 |
2024 Abril | 56 | 27 | 83 |
2024 Marzo | 66 | 31 | 97 |
2024 Febrero | 45 | 26 | 71 |
2024 Enero | 39 | 32 | 71 |
2023 Diciembre | 51 | 21 | 72 |
2023 Noviembre | 48 | 38 | 86 |
2023 Octubre | 48 | 20 | 68 |
2023 Septiembre | 63 | 26 | 89 |
2023 Agosto | 25 | 20 | 45 |
2023 Julio | 42 | 39 | 81 |
2023 Junio | 53 | 22 | 75 |
2023 Mayo | 42 | 26 | 68 |
2023 Abril | 37 | 27 | 64 |
2023 Marzo | 31 | 27 | 58 |
2023 Febrero | 39 | 22 | 61 |
2023 Enero | 31 | 32 | 63 |
2022 Diciembre | 47 | 37 | 84 |
2022 Noviembre | 21 | 23 | 44 |
2022 Octubre | 20 | 19 | 39 |
2022 Septiembre | 21 | 46 | 67 |
2022 Agosto | 21 | 22 | 43 |
2022 Julio | 19 | 24 | 43 |
2022 Junio | 16 | 19 | 35 |
2022 Mayo | 27 | 36 | 63 |
2022 Abril | 37 | 48 | 85 |
2022 Marzo | 54 | 56 | 110 |
2022 Febrero | 37 | 28 | 65 |
2022 Enero | 33 | 54 | 87 |
2021 Diciembre | 23 | 42 | 65 |
2021 Noviembre | 32 | 56 | 88 |
2021 Octubre | 36 | 53 | 89 |
2021 Septiembre | 33 | 50 | 83 |
2021 Agosto | 30 | 38 | 68 |
2021 Julio | 25 | 43 | 68 |
2021 Junio | 40 | 36 | 76 |
2021 Mayo | 43 | 33 | 76 |
2021 Abril | 72 | 54 | 126 |
2021 Marzo | 58 | 24 | 82 |
2021 Febrero | 57 | 21 | 78 |
2021 Enero | 36 | 28 | 64 |
2020 Diciembre | 30 | 14 | 44 |
2020 Noviembre | 22 | 16 | 38 |
2020 Octubre | 24 | 6 | 30 |
2020 Septiembre | 28 | 9 | 37 |
2020 Agosto | 33 | 30 | 63 |
2020 Julio | 25 | 10 | 35 |
2020 Junio | 35 | 28 | 63 |
2020 Mayo | 22 | 13 | 35 |
2020 Abril | 34 | 25 | 59 |
2020 Marzo | 35 | 26 | 61 |
2020 Febrero | 1 | 12 | 13 |
2020 Enero | 0 | 12 | 12 |
2019 Diciembre | 3 | 5 | 8 |
2019 Noviembre | 0 | 6 | 6 |
2019 Septiembre | 4 | 0 | 4 |
2019 Agosto | 0 | 6 | 6 |
2019 Julio | 0 | 6 | 6 |
2019 Junio | 2 | 5 | 7 |
2019 Mayo | 1 | 8 | 9 |
2019 Abril | 0 | 5 | 5 |
2019 Marzo | 2 | 8 | 10 |
2019 Febrero | 0 | 2 | 2 |
2019 Enero | 2 | 1 | 3 |
2018 Diciembre | 2 | 7 | 9 |
2018 Noviembre | 1 | 0 | 1 |
2018 Octubre | 4 | 0 | 4 |
2018 Septiembre | 3 | 0 | 3 |
2018 Julio | 0 | 2 | 2 |
2018 Abril | 0 | 3 | 3 |
2018 Febrero | 20 | 3 | 23 |
2018 Enero | 22 | 7 | 29 |
2017 Diciembre | 25 | 8 | 33 |
2017 Noviembre | 16 | 9 | 25 |
2017 Octubre | 17 | 5 | 22 |
2017 Septiembre | 18 | 12 | 30 |
2017 Agosto | 22 | 7 | 29 |
2017 Julio | 18 | 9 | 27 |
2017 Junio | 31 | 9 | 40 |
2017 Mayo | 18 | 4 | 22 |
2017 Abril | 19 | 14 | 33 |
2017 Marzo | 20 | 39 | 59 |
2017 Febrero | 14 | 8 | 22 |
2017 Enero | 18 | 12 | 30 |
2016 Diciembre | 33 | 6 | 39 |
2016 Noviembre | 25 | 24 | 49 |
2016 Octubre | 35 | 11 | 46 |
2016 Septiembre | 32 | 4 | 36 |
2016 Agosto | 42 | 13 | 55 |
2016 Julio | 41 | 18 | 59 |
2016 Junio | 15 | 11 | 26 |
2016 Mayo | 9 | 20 | 29 |
2016 Abril | 10 | 1 | 11 |
2016 Marzo | 8 | 1 | 9 |
2016 Febrero | 4 | 4 | 8 |
2016 Enero | 8 | 1 | 9 |
2015 Diciembre | 6 | 1 | 7 |
2015 Noviembre | 13 | 1 | 14 |
2015 Octubre | 10 | 4 | 14 |
2015 Septiembre | 8 | 3 | 11 |
2015 Agosto | 7 | 1 | 8 |
2015 Julio | 55 | 17 | 72 |
2015 Junio | 46 | 7 | 53 |
2015 Mayo | 77 | 15 | 92 |
2015 Abril | 72 | 11 | 83 |
2015 Marzo | 32 | 11 | 43 |
2015 Febrero | 42 | 11 | 53 |
2015 Enero | 23 | 13 | 36 |
2014 Diciembre | 33 | 19 | 52 |
2014 Noviembre | 9 | 7 | 16 |
2014 Octubre | 24 | 7 | 31 |
2014 Septiembre | 14 | 8 | 22 |
2014 Agosto | 16 | 5 | 21 |
2014 Julio | 9 | 6 | 15 |
2014 Junio | 32 | 4 | 36 |
2014 Mayo | 34 | 8 | 42 |
2014 Abril | 8 | 2 | 10 |
2014 Marzo | 7 | 3 | 10 |
2014 Febrero | 9 | 5 | 14 |
2014 Enero | 11 | 1 | 12 |
2013 Diciembre | 15 | 2 | 17 |
2013 Noviembre | 14 | 5 | 19 |
2013 Octubre | 8 | 3 | 11 |
2013 Septiembre | 7 | 1 | 8 |
2013 Agosto | 9 | 4 | 13 |
2013 Julio | 7 | 7 | 14 |
2013 Junio | 4 | 7 | 11 |
2013 Mayo | 7 | 2 | 9 |
2013 Abril | 16 | 5 | 21 |
2013 Marzo | 15 | 5 | 20 |
2013 Febrero | 25 | 4 | 29 |
2013 Enero | 23 | 13 | 36 |
2012 Diciembre | 14 | 5 | 19 |